Furthermore, we found that up-regulation of VRK1 promoted cisplatin (CDDP) resistance in ESCC both in vitro and in vivo, whereas knockdown of VRK1 reduced this resistance. The gene discussed is VRK1; the disease is esophageal squamous cell carcinoma.